Technology - Software - Application - NASDAQ - US
$ 3.22
-3.01 %
$ 395 M
Market Cap
-4.35
P/E
Waldencast Acquisition Corp. a skin care company, provides advanced skin care treatments. Its products are designed to help minimize the appearance of premature skin aging, skin damage, hyperpigmentation, acne, and sun damage primarily available through dermatologists, plastic surgeons, medical spas, and other skin care professionals. Its portfolio includes Obagi Medical that provides transformational skin care products formulated to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines, and wrinkles and to protect and enhance skin tone and texture; and Obagi Clinical that offers skin care products designed to prevent the early signs of skin aging. The company was founded in 1988 and is based in White Plains, New York.[ Read More ]
The intrinsic value of one WALD stock under the base case scenario is HIDDEN Compared to the current market price of 3.22 USD, Waldencast plc is HIDDEN
2. FUNDAMENTAL
ANALYSIS
Price Chart WALD
FINANCIALS
218 M
REVENUE
-81.9 M
OPERATING INCOME
-90 M
NET INCOME
-29.8 M
OPERATING CASH FLOW
-1.99 M
INVESTING CASH FLOW
44.3 M
FINANCING CASH FLOW
63.3 M
REVENUE
44.6 M
OPERATING INCOME
-5.04 M
NET INCOME
-5.69 M
OPERATING CASH FLOW
-698 K
INVESTING CASH FLOW
5.66 M
FINANCING CASH FLOW
Balance Sheet Decomposition
Waldencast plc
| Current Assets | 107 M |
| Cash & Short-Term Investments | 22.6 M |
| Receivables | 22.4 M |
| Other Current Assets | 62.3 M |
| Non-Current Assets | 935 M |
| Long-Term Investments | 0 |
| PP&E | 17.5 M |
| Other Non-Current Assets | 918 M |
| Current Liabilities | 62.7 M |
| Accounts Payable | 28.1 M |
| Short-Term Debt | 10.9 M |
| Other Current Liabilities | 23.7 M |
| Non-Current Liabilities | 211 M |
| Long-Term Debt | 167 M |
| Other Non-Current Liabilities | 43.9 M |
EFFICIENCY
Earnings Waterfall
Waldencast plc
| Revenue | 218 M |
| Cost Of Revenue | 76.6 M |
| Gross Profit | 142 M |
| Operating Expenses | 224 M |
| Operating Income | -81.9 M |
| Other Expenses | 8.05 M |
| Net Income | -90 M |
RATIOS
64.90%
GROSS MARGIN
-37.56%
OPERATING MARGIN
-41.25%
NET MARGIN
-14.41%
ROE
-8.63%
ROA
-9.80%
ROIC
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Waldencast plc
| Net Income | -90 M |
| Depreciation & Amortization | 60.5 M |
| Capital Expenditures | -2.05 M |
| Stock-Based Compensation | 9.24 M |
| Change in Working Capital | 95 K |
| Others | -2.35 M |
| Free Cash Flow | -31.8 M |
Wall Street Analysts Price Targets
Waldencast plc
Wall Street analysts predict an average 1-year price target for WALD of $10.1 , with forecasts ranging from a low of $6.5 to a high of $15.5 .
WALD Lowest Price Target
Wall Street Target
6.5 USD
101.86%
WALD Average Price Target
Wall Street Target
10.1 USD
214.44%
WALD Highest Price Target
Wall Street Target
15.5 USD
381.37%
4. DIVIDEND ANALYSIS
0.00%
DIVIDEND YIELD
0 USD
DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership
Waldencast plc
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
| Date | Value | Insider | Amount | Avg Price |
|---|
7. News
Waldencast plc Announces Third Quarter Fiscal 2024 Results Conference Call and Webcast
LONDON, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform provided the details for its Third Quarter Fiscal 2024 conference call and webcast. As previously announced, the Company will issue its Third Quarter Fiscal 2024 results on November 20, 2024 after the close of the U.S. market.
globenewswire.com
- 3 days ago
Waldencast plc Announces Board Appointments and Annual General Meeting
NEW YORK, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), a global multi-brand beauty and wellness platform, announced today that Hind Sebti, Kelly Brookie and Roberto Thompson have been appointed to its board of Directors (the “Board”), effective September 26, 2024. These executives bring extensive professional experience further enhancing the breadth of talent and expertise possessed by the Board. Ms. Brookie will replace Sarah Brown who has informed the Board of her intention to not renew her mandate ahead of the Company's Annual General Meeting. The Company also announced that its Annual General Meeting is scheduled for October 28, 2024 during which the Company's shareholders will be asked to vote on the renewal of Class I and Class II directors. Following this announcement, the Board will include 11 members, each of whom possesses significant expertise, particularly in the beauty, financial and consumer products sectors.
globenewswire.com
- 1 month ago
Obagi Medical Announces the Launch of ELASTIDERM® Lift Up & Sculpt Facial Moisturizer and ELASTIDERM® Advanced Filler Concentrate
These New Products are the Latest Innovation to Obagi's ELASTIDERM® Collection These New Products are the Latest Innovation to Obagi's ELASTIDERM® Collection
globenewswire.com
- 2 months ago
Waldencast plc (WALD) Q2 2024 Earnings Call Transcript
Waldencast plc. (NASDAQ:WALD ) Q2 2024 Earnings Conference Call August 28, 2024 8:30 AM ET Company Participants Allison Malkin - Investor Relations, ICR Michel Brousset - Founder & Chief Executive Officer Manuel Manfredi - Chief Financial Officer Conference Call Participants Olivia Tong - Raymond James Linda Bolton Weiser - DA Davidson Dana Telsey - Telsey Advisory Group Operator Greetings.
seekingalpha.com
- 2 months ago
Why Waldencast Stock Is Skyrocketing Today
Waldencast posted Q2 sales that came in far above the market's expectations. Comparable sales growth accelerated significantly on a sequential quarterly basis.
fool.com
- 2 months ago
Waldencast Reports Q2 2024 Financial Results
$63.3 million of Net Revenue Q2 2024 +25.7% net revenue Comparable Growth: +30.9% Obagi Medical and +20.0% Milk Makeup vs Q2 2023 Adjusted EBITDA of $6.3 million, up +64.5% vs Q2 2023
globenewswire.com
- 2 months ago
Waldencast plc Provides Second Quarter and First Half Fiscal 2024 Earnings Conference Call and Webcast Information
NEW YORK, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, provided second quarter and first half fiscal 2024 earnings conference call and webcast information. As previously announced, the Company will report second quarter and first half fiscal 2024 earnings on August 27th, after the close of the U.S. stock market. The Company will conduct a conference call to discuss its earnings results on Wednesday, August 28, 2024 at 8:30am ET.
globenewswire.com
- 2 months ago
4 Cosmetics Stocks Worth Watching Amid Industry Challenges
The Zacks Cosmetics industry is grappling with elevated inflationary pressures. Coty, Inter Parfums (IPAR), Waldencast (WALD) and Olaplex (OLPX) are capitalizing on digital advancements and innovative strategies.
zacks.com
- 3 months ago
Waldencast Announces Participation in the Canaccord Genuity 44th Annual Growth Conference
WHITE PLAINS, N.Y., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), a global multi-brand beauty and wellness platform, today announced that the Company will participate in the Canaccord Genuity 44th Annual Growth Conference being held at the InterContinental Boston Hotel in Boston, Massachusetts.
globenewswire.com
- 3 months ago
Waldencast plc Announces Upcoming Earnings Release and Conference Call Dates
WHITE PLAINS, N.Y., June 27, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, announced upcoming earnings release, conference call and webcast dates.
globenewswire.com
- 4 months ago
Waldencast Announces Participation in Upcoming Investor Conferences
WHITE PLAINS, N.Y., May 30, 2024 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), a global multi-brand beauty and wellness platform, today announced that the Company will participate in upcoming investor conferences.
globenewswire.com
- 5 months ago
Waldencast Reports Q1 2024 Financial Results
$68.3 million of Net Revenue+21.0% Comparable Net Revenue: +20.6% Obagi Skincare and +21.5% Milk MakeupAdjusted EBITDA of $11.4 million, up +12.9% vs Q1 2023
globenewswire.com
- 5 months ago
8. Profile Summary
Waldencast plc WALD
COUNTRY
US
INDUSTRY
Software - Application
MARKET CAP
$ 395 M
Dividend Yield
0.00%
Description
Waldencast Acquisition Corp. a skin care company, provides advanced skin care treatments. Its products are designed to help minimize the appearance of premature skin aging, skin damage, hyperpigmentation, acne, and sun damage primarily available through dermatologists, plastic surgeons, medical spas, and other skin care professionals. Its portfolio includes Obagi Medical that provides transformational skin care products formulated to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines, and wrinkles and to protect and enhance skin tone and texture; and Obagi Clinical that offers skin care products designed to prevent the early signs of skin aging. The company was founded in 1988 and is based in White Plains, New York.
Contact
10 Bank Street, White Plains, NY, 10606
http://www.waldencast.com
IPO Date
May 12, 2021
Employees
284
Officers
Ms. Hind Sebti
Co-Founder, Chief Growth Officer & Director
Elisabeth Milan
General Counsel
Mr. Michel Brousset
Founder, Chief Executive Officer & Director
Mr. Manuel Manfredi
Chief Financial Officer